Skip to main content

Researches Our research spans a wide range from basic organic synthesis, drug design and development, structure elucidation of newly synthesized compound and natural products. The research focuses on the following strategic Research Themes: Design and synthesis of new chemical entities. Computer aided drug design studies. Structure-Activity relationship studies. Combinatorial chemistry. Prod rugs developments. Analytical methods for bioavailability and metabolic studies. Research within these Themes is carried out in multidisciplinary groupings focused on the discovery of novel techniques and/or enhancement of the already existing ones. At the department of Medicinal Pharmacy, We have major national and international collaborative research projects and a significant output of research publications in high-ranking journals. Our academic collaborators include many Universities in USA, Canada, Japan, and a number of major European universities.

# Title Research Year
261 Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity 2007
262 Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity 2007
263 Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity 2007
264 Murine Hepatoma (Hepa1c1c7) Cells: A Responsive In Vitro System for Chemoprotective Enzyme Induction by Organoselenium Compounds

2007
265 Novel beta-peptides from L-aspartic acid and beta-amino-4-alanine: Solution conformation and stability studies 2007
266 Pre- and post-initiation chemoprevention activity of 2-alkyl/aryl selenazolidine-4(R)-carboxylic acids against tobacco-derived nitrosamine (NNK)-induced lung tumors in the A/J mouse

2007
267 Synthesis and three-dimensional qualitative structure selectivity relationship of 3,5-disubstituted-2,4 thiazolidinedione derivatives as COX-2 inhibitors 2007
268 Synthesis and three-dimensional qualitative structure selectivity relationship of 3,5-disubstituted-2,4 thiazolidinedione derivatives as COX-2 inhibitors 2007
269 Synthesis and three-dimensional qualitative structure selectivity relationship of 3,5-disubstituted-2,4 thiazolidinedione derivatives as COX-2 inhibitors 2007
270 Synthesis and three-dimensional qualitative structure selectivity relationship of 3,5-disubstituted-2,4 thiazolidinedione derivatives as COX-2 inhibitors 2007